Efficacy and Safety of KRAS G12C Inhibitor IBI351 Monotherapy in Patients With Advanced NSCLC: Results From a Phase 2 Pivotal Study
Qing Zhou, Xiangjiao Meng, Longhua Sun, Dingzhi Huang, Nong Yang, Y. Yu, Mingfang Zhao, Wu Zhuang, Renhua Guo, Yi Fan Hu, Yueyin Pan, Jinlu Shan, Meili Sun, Ying Yuan, Yun Fan, Jianan Huang, Lian Liu, Qian Chu, Xiuwen Wang, Chong‐Rui Xu, Jiaxin Lin, Jingjing Huang, Mengna Huang, Jiya Sun, Sujie Zhang, Hui Zhou, Yi‐Long Wu
Topics & Concepts
MedicineKRASLung cancerOncologyCancerInternal medicinePhases of clinical researchClinical trialColorectal cancerProtein Kinase Regulation and GTPase SignalingColorectal Cancer Treatments and StudiesMelanoma and MAPK Pathways